UNICA IRIS Institutional Research Information System

CORONA, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 272.254
NA - Nord America 11.465
AS - Asia 5.333
SA - Sud America 828
Continente sconosciuto - Info sul continente non disponibili 677
AF - Africa 186
OC - Oceania 14
Totale 290.757
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 269.361
US - Stati Uniti d'America 11.263
SG - Singapore 2.053
CN - Cina 1.716
SE - Svezia 690
BR - Brasile 617
UA - Ucraina 504
VN - Vietnam 487
DE - Germania 369
FI - Finlandia 309
FR - Francia 253
GB - Regno Unito 238
HK - Hong Kong 192
BD - Bangladesh 171
IN - India 147
BY - Bielorussia 120
CA - Canada 112
KR - Corea 93
AR - Argentina 89
NL - Olanda 88
AT - Austria 62
JP - Giappone 61
MA - Marocco 61
IQ - Iraq 55
PK - Pakistan 54
MX - Messico 53
ZA - Sudafrica 42
PL - Polonia 40
TR - Turchia 40
ES - Italia 37
RU - Federazione Russa 37
ID - Indonesia 32
IR - Iran 32
BE - Belgio 30
EC - Ecuador 30
SA - Arabia Saudita 30
CO - Colombia 27
IE - Irlanda 21
VE - Venezuela 21
UZ - Uzbekistan 20
KE - Kenya 16
PH - Filippine 16
TN - Tunisia 16
EG - Egitto 15
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
CZ - Repubblica Ceca 13
IL - Israele 13
JO - Giordania 13
NP - Nepal 13
AZ - Azerbaigian 12
AU - Australia 11
MY - Malesia 11
DK - Danimarca 10
BO - Bolivia 9
ET - Etiopia 9
DZ - Algeria 8
GE - Georgia 8
JM - Giamaica 8
LT - Lituania 8
LV - Lettonia 8
UY - Uruguay 8
AL - Albania 7
CH - Svizzera 7
EU - Europa 7
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
NO - Norvegia 6
PT - Portogallo 6
PY - Paraguay 6
CR - Costa Rica 5
NI - Nicaragua 5
PE - Perù 5
RO - Romania 5
GT - Guatemala 4
HN - Honduras 4
PA - Panama 4
DO - Repubblica Dominicana 3
LB - Libano 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
OM - Oman 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
A1 - Anonimo 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CI - Costa d'Avorio 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
RS - Serbia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
Totale 290.061
Salva come PNG Salva come JPEG
Città #
Cagliari 262.033
Uta 6.195
Ashburn 1.125
Singapore 1.115
Fairfield 842
San Jose 728
Woodbridge 702
Dallas 562
Chandler 560
Boardman 478
Nyköping 431
Houston 416
Seattle 364
Beijing 355
Wilmington 346
Ann Arbor 313
Council Bluffs 312
Los Angeles 300
Cambridge 281
New York 247
Jacksonville 226
Helsinki 207
Santa Clara 197
Dearborn 190
Hong Kong 167
Shanghai 155
The Dalles 151
Ho Chi Minh City 142
Lauterbourg 134
Hefei 117
Boston 113
Nanjing 109
Dong Ket 98
Hanoi 84
Rome 82
Seoul 81
Chicago 79
Buffalo 73
Columbus 69
Milan 67
San Diego 65
Munich 61
Redwood City 61
São Paulo 54
Herndon 47
Tokyo 45
Casablanca 44
Vienna 42
Orem 41
Guangzhou 40
Amsterdam 38
Hangzhou 38
Phoenix 37
Redondo Beach 37
Changsha 36
London 36
Tianjin 35
Atlanta 34
Frankfurt am Main 34
Toronto 33
Mountain View 32
Sassari 32
Nanchang 29
Rio de Janeiro 29
Verona 29
Washington 29
Brooklyn 28
Shenyang 28
Warsaw 28
Redmond 26
Salt Lake City 26
Chennai 25
Nuremberg 24
Jiaxing 23
Hebei 22
Lappeenranta 22
Montreal 22
San Francisco 22
Johannesburg 21
Brussels 20
Denver 20
Mumbai 20
Dublin 19
Mexico City 19
Norwalk 19
Tashkent 19
Baghdad 18
Naples 18
Ottawa 17
Gujranwala 16
Manchester 16
Curitiba 15
Lahore 15
Wuhan 15
Zhengzhou 15
Des Moines 14
Dhaka 14
Guayaquil 14
Jinan 14
Nairobi 14
Totale 281.952
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.733
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.069
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.694
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.541
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.494
Biological activities of aerial parts extracts of Euphorbia characias 4.450
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.336
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.198
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.761
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.520
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.467
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.455
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.446
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.419
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.385
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.363
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.319
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.318
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.304
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.284
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.217
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.120
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.113
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.090
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 3.063
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.059
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.048
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 3.008
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 3.007
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.987
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.939
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.939
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.933
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.931
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.891
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.880
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.879
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.873
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.832
Insights into Ebola VP35 oligomerization from molecular simulations 2.818
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.791
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.779
null 2.746
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.737
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.715
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.662
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.647
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.624
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.580
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.469
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.441
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.435
An efficient route to novel uracil-based drug-like molecules 2.375
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.373
null 2.329
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.320
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.280
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.266
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.234
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.164
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.155
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.141
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.118
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.115
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.097
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.080
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.067
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.984
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.898
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.893
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.891
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.887
Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H 1.839
null 1.820
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.810
The traditional Chinese medicine plant Schisandra Chinensis as source of new HIV-1 reverse transcriptase inhibitor scaffolds effective also on non-nucleoside resistant reverse transcriptases 1.809
New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function 1.727
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.715
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 1.687
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.642
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.618
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen 1.586
From classic to innovative approaches in HIV-1 infection treatment 1.571
Hypericum hircinum L. components as new single molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. 1.563
Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives 1.546
2-methoxynaphthalen thiazole derivate : a new HIV-1 RT Ribonuclease H/DNA polymerase dual inhibitor active on viral replication 1.538
Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2 1.465
Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development? 1.442
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production 1.440
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules 1.433
Peptides Mimicking the β7/β8 loop of HIV-1 Reverse Transcriptase p51 as “Hotspot-Targeted” Dimerization Inhibitors 1.424
5-arylaminouracil derivatives as potential dual-action agents 1.360
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities 1.314
Natural and Nature-Derived Products Targeting Human Coronaviruses 1.305
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation 1.293
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort 1.233
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.212
A combined cell based and site directed mutagenesis approach defines highly conserved residues involved in the selective inhibition of the HIV-1 ribonuclease H function by diketoacid derivatives 1.148
In Vitro Anti-HIV-1 Reverse Transcriptase and Integrase Properties of Punica granatum L. Leaves, Bark, and Peel Extracts and Their Main Compounds 1.129
The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry 1.062
Totale 263.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 354.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 354.542
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214.065 0 1.302 877 903 1.139 1.247 897 907 1.513 1.470 1.799 2.011
2022/202326.453 2.280 3.722 3.079 2.423 1.570 2.878 1.282 1.827 1.399 1.519 2.128 2.346
2023/202424.258 1.620 862 1.324 1.822 2.331 4.147 3.191 2.097 1.158 1.331 2.071 2.304
2024/202550.727 13.089 15.338 7.484 4.880 2.332 2.847 2.652 236 492 377 448 552
2025/202612.949 877 412 1.483 1.103 1.099 795 2.189 1.149 829 1.512 913 588
2026/2027831 379 452 0 0 0 0 0 0 0 0 0 0
Totale 290.757